JoVE Logo
Faculty Resource Center

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

Abstract

Immunology and Infection

マウス自然発症自己免疫性甲状腺炎モデルの作製

Published: March 17th, 2023

DOI:

10.3791/64609

1Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University, 2The Laboratory of Thyroid and Parathyroid Disease, West China Hospital of Sichuan University, 3State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center

ERRATUM NOTICE

Important: There has been an erratum issued for this article. Read more …

Abstract

近年、橋本甲状腺炎(HT)が最も一般的な自己免疫性甲状腺疾患となっています。リンパ球の浸潤および特異的血清自己抗体の検出を特徴とする。潜在的なメカニズムはまだ明らかではありませんが、橋本甲状腺炎のリスクは遺伝的および環境的要因に関連しています。現在、実験的自己免疫性甲状腺炎(EAT)や自然自己免疫性甲状腺炎(SAT)など、自己免疫性甲状腺炎のモデルにはいくつかの種類があります。

マウスのEATはHTの一般的なモデルであり、リポ多糖(LPS)とサイログロブリン(Tg)を組み合わせた免疫、または完全なフロイントアジュバント(CFA)を補充します。EATマウスモデルは、多くの種類のマウスで広く確立されています。ただし、疾患の進行はTg抗体応答に関連している可能性が高く、実験によって異なる場合があります。

SATは、NODにおけるHTの研究にも広く使用されています。H-2H4マウス。うなずく。H2h4マウスは、非肥満糖尿病(NOD)マウスとB10との交配から得られた新しい系統である。A(4R)は、ヨウ素の供給の有無にかかわらずHTに対して有意に誘導されます。誘導中、NOD.H-2h4マウスは、甲状腺濾胞組織におけるリンパ球浸潤を伴う高レベルのTgAbを有する。しかし、この種のマウスモデルでは、ヨウ素誘導時の病理学的過程を総合的に評価する研究はほとんどない。

本研究では、HT研究のためのSATマウスモデルを確立し、長期間のヨウ素誘導後に病理学的変化プロセスを評価します。このモデルを通じて、研究者はHTの病理学的発達をよりよく理解し、HTの新しい治療法をスクリーニングすることができます。

Erratum

Erratum: Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

An erratum was issued for: Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model. The Protocol section was updated.

Step 3.1.1 of the Protocol was updated from:

After the induction, anesthetize the mice with a volume of 0.01 mL/g anesthetic by intraperitoneal injection. Prepare the anesthetic by mixing midazolam (40 µg/100 µL for sedation), medetomidine (7.5 µg/100 µL for sedation), and butorphanol tartrate (50 µg/100 µL for analgesia) in phosphate-buffered saline (PBS).

to

After the induction, anesthetize the mice with a volume of 0.01 mL/g anesthetic by intraperitoneal injection. Prepare the anesthetic by mixing midazolam (40 µg/100 µL for sedation), medetomidine (7.5 µg/100 µL for sedation), and butorphanol tartrate (50 µg/100 µL for analgesia) in phosphate-buffered saline (PBS).
NOTE: The specific concentrations of each component in the anesthesia mixture are: midazolam 13.33µg/100µL, medetomidine 2.5µg/100µL, and butorphanol 16.7µg/100µL. For specific dosages used in mice, the doses are: midazolam 4µg/g, medetomidine 0.75µg/g, and butorphanol 1.67µg/g. Anesthesia depth was confirmed when the mouse's limb muscles relaxed, the whiskers had no touch response, and there was loss of  pedal reflex.

Step 3.1.2 of the Protocol was updated from:

After the mice are anesthetized, cut off their whiskers with ophthalmic scissors to prevent blood from flowing down the whiskers and causing hemolysis. Fix the mouse with one hand and press the skin of the eye to make the eyeball protrude. Quickly remove the eyeball and draw 1 mL of blood into the microcentrifuge tube via a capillary tube.

to

After the mice are anesthetized, prepare the peripheral blood samples, by fixing the mouse with one hand and pressing the eye skin to protrude the eyeball. Then, insert the capillary tube into the inner corner of the eye and penetrate at a 30-45 degree angle to the plane of the nostril. Apply pressure while gently rotating the capillary tube. Blood will flow into the tube via capillary action.

Step 3.2.1 of the Protocol was updated from:

Dissect the chest wall to expose the heart, cut open the right atrium, and infuse saline into the left ventricle by an intravenous infusion needle attached to a 20 mL syringe until the tissue turns white.

to

Humanely euthanize the animal according to the institutional policies. Then, dissect the chest wall to expose the heart, cut open the right atrium, and infuse saline into the left ventricle by an intravenous infusion needle attached to a 20 mL syringe until the tissue turns white.

Explore More Videos

193

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved